Publications
5674 Results
- Journal / Conference
- The Journal of Prevention of Alzheimer’s Disease 1(3): 259-60, 2014; Clinical Trials Conf. on Alzheimer’s Disease (Nov. 20-22, 2014, Phil., PA), poster
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000A
Normal young-old men: Results from PREADVISE
- Journal / Conference
- The Journal of Prevention of Alzheimer’s Disease, 1(3):283; 2014;Clinical Trials Conf. on Alzheimer’s Disease (November 20-22, 2014, Phil., PA), poster
- Year
- 2014
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000A
Lower quality of life scores at baseline are associated with an increased risk of future cognitive impairment: Results from PREADVISE
- Journal / Conference
- Journal of Clinical Oncology Nov 20;32(33):3744-3752
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25332249
- PMC
- PMC4226805
- Study Number(s)
- N9831
Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831
- Journal / Conference
- Journal of Clinical Oncology Dec 10;32(35):3948-3958
- Year
- 2014
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9347 (INT-0142) (E3193)
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group
- Journal / Conference
- Journal of Thoracic Oncology Oct;9(10):1443-1448
- Year
- 2014
- Research Committee(s)
- Lung
- PMID
- PMID25521397
- PMC
- PMC4165474
- Study Number(s)
- S1400
Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer
- Journal / Conference
- Journal of Clinical Oncology Dec 10;32(35):3959-3966
- Year
- 2014
- Research Committee(s)
- Breast
- PMID
- PMID25348000
- PMC
- PMC4251959
Endocrine therapy with or without inhibition of epidermal growth factor receptor and human epidermal growth factor receptor 2: a randomized, double-blind, placebo-controlled phase III trial of fulvestrant with or without lapatinib for postmenopausal women with hormone receptor-positive advanced breast cancer-CALGB 40302 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology Sep 20;32(27):3059-3068
- Year
- 2014
- Research Committee(s)
- Lymphoma
- PMID
- PMID25113753
- PMC
- PMC4979083
Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification Consortium [includes representation by SWOG]
- Journal / Conference
- Journal of Translational Medicine Oct 28;12(1):277
- Year
- 2014
- Research Committee(s)
- Melanoma
- PMID
- PMID25348889
- PMC
- PMC4232645
- Study Number(s)
- S0008, S1404
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013
- Journal / Conference
- Asian Journal of Andrology May-Jun;16(3):414
- Year
- 2014
- Research Committee(s)
- Cancer Control
- PMID
- PMID24914438
- PMC
- PMC4023368
- Study Number(s)
- SWOG-9217
Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology 32:5s(suppl; abstr 632); ASCO Annual Meeting (May 30-June 3, 2014, Chicago, IL), general poster session;
- Year
- 2014
- Research Committee(s)
- Breast